Trends & Forecasts

PicnicHealth Co-founder and CEO Noga Leviner foresees AI as the augur of greater observational research

Alfred Marchler and Peter Hirst discuss the biggest disruptors shaping the next decade.

A rundown of the latest developments and approvals in the world of small molecules drugs manufacturing.

Jason Bock highlights the need for innovative manufacturing solutions and supply chain improvements in cell therapy.

Technological advances are opening up new drug development opportunities for rare diseases.

The increasing focus on sustainability in the pharmaceutical industry amongst CDMOs reveals the key strategies and initiatives being undertaken.

Counterfeit medicines pose a significant threat to global health. A recent study uncovers alarming facts and emphasizes the need for solutions.

Delali Attipoe at the DNDi explains why we need an R&D model attuned to the needs of forgotten patients.

What does the future hold for pharma? Audrey Greenberg and Jon Zwinski give their views.

As part of our 10-year anniversary special feature, Markus Kosch tells us his views on the future of pharma.